Gastrointestinal Manifestations of Cystic Fibrosis

1. Durie PR . Pancreatitis and mutations of the cystic fibrosis gene [editorial; comment]. N Engl J Med. 1998;339: 687-688.

2. Riordan JR , Rommens JM , Kerem B , et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA [published erratum appears in Science 1989 Sep 29;245:1437]. Scwnce. 1989;245:1066-1073.

3. Cohn JA , Friedman KJ , Noone PG , et al. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med. 1998; 339:653-658.

4. Sharer N , Schwarz M , Malone G , et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med. 1998;339:645-652.

5. Corey M , Gaskin K , Durie P , et al. Improved prognosis in CF patients with normal fat absorption. J Pediatr Gastroenterol Nutr. 1984;3 (suppl 1):S99-S105.

6. Lewis TC , Casey SC , Kapur RP . Clinical pathologic correlation: a 3-year old boy with cystic fibrosis and intestinal obstruction. J Pediatr. 1999; 134:514-519.

7. Coutts JA , Docherty JG , Carachi R , Evans TJ . Clinical course of patients with cystic fibrosis presenting with meconium ileus. Br. J Surg. 1997; 84:555-555.

8. Irish MS , Ragi JM , Karamanoukian H , et al. Prenatal diagnosis of the fetus with cystic fibrosis and meconium ileus. Pediatr Surg Int. 1997;12:434-436.

9. Koletzko S , Stringer DA , Cleghorn GJ , Durie PR . Lavage treatment of distal intestinal obstruction syndrome in children with cystic fibrosis. Pediatrics. 1989;83:727-733.

10. Stern RC , Izant RJ Jr , Boat TF , et al. Treatment and prognosis of rectal prolapse in cystic fibrosis. Gastroenterology. 1982;82:707-710.

11. Freiman JP , FitzSimmons SC . Colonic strictures in patients with cystic fibrosis: results of a survey of 114 cystic fibrosis care centers in the United States. J Pediatr Gastroenterol Nutr. 1996;22:153-156.

12. Kapadia C . Fibrosing colonopathy in cystic fibrosis: results of a case-control study. Gastroenterology. 1996;111:260-261.

13. Bayless TM , Tokayer AZ , Polito JM , et al. Crohn's disease: concordance for site and clinical type in affected family members-potential hereditary influences. Gastroenterology. 1996;11:573-579.

14. Schwarzenberg SJ , Wielinski CL , Shamieh I , et al. Cystic fibrosis-associated colitis and fibrosing colonopathv. J Pediatr. 1995;127:565-570.

15. Smyth RL , van Velzen D , Smyth AR , et al. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet. 1994;343:85-86.

16. Taylor CJ . Colonic strictures in cystic fibrosis. Lancet. 1994;343:615-616.

17. Taylor CJ , Dodge JA . High-strength pancreatic enzyme supplements and large-bowel stricture in cystic fibrosis. Lancet. 1994;343:110-110.

18. Haber HP , Lang A , Drews K , Stern M . Colonic wall thickening in cystic fibrosis identified by ultrasound. J Pediatr Gastroenterol Nutr. 1996;23:487-491.

19. Borowitz DS , Grand RJ , Durie PR . Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee. J Pediatr. 1995; 127:681-684.

20. Stevens JC , Maguiness KM , Hollingsworth J , et al. Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy. J Pediatr Gastroenterol Nutr. 1998;26:80-84.

21. Scott-Jupp R , Lama M , Tanner MS . Prevalence of liver disease in cystic fibrosis. Arch Dis Child. 1991;66:698-701.

22. Colombo C , Battezzati PM , Podda M . Hepatobiliary disease in cystic fibrosis. Semin Liver Dis. 1994;14:259-269.

23. Colombo C , Battezzati PM . Hepatobiliary manifestations of cystic fibrosis. Eur JGastroenterolHepatoL 1996;8:748-754.

24. Duthie A , Doherty DG , Williams C , et al. Genotype analysis for delta F508, G551D, and R553X mutations in children and young adults with cystic fibrosis with and without chronic liver disease. Hepatology. 1992;15:660-664.

25. Waters DL , Dorney SF , Gruca MA , et al. Hepatobiliary disease in cystic fibrosis patients with pancreatic sufficiency. Hepatology. 1995;21:963-969.

26. Feigelson J , Anagnostopoulos C , Poquet M , et al. Liver cirrhosis in cystic fibrosis-therapeutic implications and long-term follow-up. Arch Dis Child. 1993;68:653-657.

27. Kerns SR , Hawkins IF Jr. Transjugular intrahepatic portosystemic shunt in a child with cystic fibrosis. Am J Roentgenol 1992;159:1277-1278.

28. Noble-Jamieson G , Valente J , Barnes ND , et al. Liver transplantation for hepatic cirrhosis in cystic fibrosis. Arch Dis Child. 1994;71:349-352.

29. Noble-Jamieson G , Barnes ND . Liver transplantation for cirrhosis in cystic fibrosis [letter]. J Pediatr. 1996; 129:314-314.

30. Noble-Jamieson G , Barnes N , Jamieson N , et al. Liver transplantation for hepatic cirrhosis in cystic fibrosis. JR Soc Med. 1996;89 (suppl 27):31-37.

31. Cox KL , Ward RE , Furgiuele TL , et al. Orthotopic liver transplantation in patients with cystic fibrosis. Pediatrics. 1987;80:571-574.

32. Couetil JP , Houssin DP , Soubrane O , et al. Combined lung and liver transplantation in patients with cystic fibrosis. A 4⅓-year experience. J Thorac Cardiovasc Surg. 1995;110:1415-1422.

33. Colombo C , Castellani MR , Balistreri WF , et al. Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease. Hepatology. 1992; 15:677-684.

34. Colombo C , Battezzati PM , Podda M , et al. Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis. Hepatology. 1996;23:1484-1490.

35. Cotting J , Lentze MJ , Reichen J . Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis. Gut. 1990;31:918-921.

36. Gaskin KJ , Waters DL , Howman-Giles F , et al. Liver disease and commonbile-duct stenosis in cystic fibrosis. N Engl J Med. 1988;318:340-346.